IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, ...
Bank of America Securities analyst Didier Scemama reiterated a Hold rating on STMicroelectronics NV (0INB – Research Report) today and set a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback